Search

Mibefradil

Mibefradil was withdrawn from the market in 1998 because of potentially harmful interactions with other drugs.

Propacetamol

Propacetamol is a parenteral formulation of paracetamol and thus, it is a prodrug that is completely hydrolyzed to paracetamol. … [A7892] It is not available in the United States but this prodrug has been widely used in other countries such as France since 1985.[L1505]

Lumiracoxib

New Zealand and Canada have also followed suit in recalling the drug. … Lumiracoxib is a COX-2 selective non-steroidal anti-inflammatory drug (NSAID).

Dapsone

It is also used with pyrimethamine in the treatment of malaria. (From Martindale, The Extra Pharmacopoeia, 30th ed, p157-8) … Its mechanism of action is probably similar to that of the sulfonamides which involves inhibition of folic acid synthesis in susceptible organisms.

Angelica sinensis root

Angelica sinensis root is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

Umbralisib

Marginal zone lymphoma is a rare, slowly progressing type of non-Hodgkin lymphoma initially treated with [rituximab] (an anti-CD20 drug), either alone or in combination with chemotherapy. … It was marketed as Ukoniq by TG Therapeutics and has been approved for the treatment of relapsing and refractory marginal cell lymphoma and follicular lymphoma in adults.

Taliglucerase alfa

It was approved in 2012 and is marketed under the name Elelyso for use in patients with type 1 Gaucher's disease. … Taliglucerase alfa is the recombinant active form of the human lysosomal enzyme, β-glucocerebrosidase.

Hydroxyamphetamine

stinging in the eyes. … It is indirect sympathomimetic agent which cause dilation of the eye pupil before diagnostic test.

Mercaptopurine

It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia.

Potassium sulfate